Search Orphan Drug Designations and Approvals
-
Generic Name: | imatinib mesylate |
---|---|
Date Designated: | 05/06/2014 |
Orphan Designation: | Treatment of progressive multifocal leukencephalopathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Inhibikase Therapeutics, Inc. 3350 Riverwood Parkway Atlanta, Georgia 30339 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-